77 studies found for:    "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
1 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
2 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
3 Completed Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: pravastatin;   Drug: Placebo
4 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
5 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
6 Completed Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome
Conditions: Joubert Syndrome;   Cerebello-oculo-renal Syndromes
Intervention: Biological: Whole blood sample
7 Recruiting Evaluation of Gut Bacteria in Patients With Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention:
8 Completed Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)
Condition: Polycystic Liver Disease
Intervention: Drug: Lanreotide
9 Terminated The Relation Between Uric Acid Level and Endothelial Dysfunction in Patients With Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Intervention:
10 Completed The Vienna RAP Pilot Study
Condition: ADPKD
Intervention: Drug: Sirolimus
11 Completed The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Behavioral: High Sodium Diet;   Behavioral: Low Sodium Diet
12 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
13 Terminated
Has Results
Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD): The Role of Biomarkers in Predicting a Response to Therapy
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Rapamycin;   Other: Standard of Care-Placebo
14 Recruiting Pasireotide LAR in Severe Polycystic Liver Disease
Conditions: Somatostatin Analogs;   Polycystic Liver Disease;   Autosomal Dominant Polycystic Kidney Disease;   Autosomal Dominant Polycystic Liver Disease
Interventions: Drug: Pasireotide LAR;   Drug: Placebo
15 Recruiting Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
Conditions: Polycystic Liver Disease (PLD):;   Polycystic Kidney, Autosomal Dominant;   Polycystic Liver Disease
Intervention: Drug: Ursodeoxycholic Acid
16 Completed Effects of Somatostatin on ADPKD Heart
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Glomerular Filtration Rate > 40 ml/Min
Interventions: Drug: Octeotride;   Drug: Placebo
17 Active, not recruiting A New Diet for Patients With Autosomal Dominant Polycystic Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Other: ADPKD Diet
18 Recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
19 Completed Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety
Condition: Polycystic Kidney
Interventions: Drug: Sirolimus;   Drug: conventional therapy
20 Completed Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Other: Standard

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years